Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allosensitization”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Very early researchWithdrawnNCT05862766
What this trial is testing

Isatuximab in Lung Transplant Recipients

Who this might be right for
Antibody-mediated RejectionAllosensitization
NYU Langone Health
Not applicableLooking for participantsNCT01999361
What this trial is testing

Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

Who this might be right for
Type 1 Diabetes Mellitus
Rodolfo Alejandro 18
Testing effectiveness (Phase 2)Study completedNCT04204980
What this trial is testing

Desensitization in Kidney Allograft Using Daratumumab

Who this might be right for
AllosensitizationKidney Transplant RejectionAntibody-mediated Rejection
Assistance Publique - Hôpitaux de Paris 21
Not applicableEnded earlyNCT01005316
What this trial is testing

Alloantibodies in Pediatric Heart Transplantation

Who this might be right for
Pediatric Heart TransplantationPediatric Heart Transplant Recipients
National Institute of Allergy and Infectious Diseases (NIAID) 290
Post-approval studies (Phase 4)Ended earlyNCT03689075
What this trial is testing

Extended Release Versus Immediate Release Tacrolimus Following Renal Allograft Failure to Reduce Allosensitisation

Who this might be right for
Kidney Transplant FailureAllosensitizationImmunosuppression
Imperial College Healthcare NHS Trust 35
Early research (Phase 1)Study completedNCT04610320
What this trial is testing

Daratumumab-SC for Highly Sensitized Patients Awaiting Heart Transplantation

Who this might be right for
AllosensitizationHeart Transplant Failure and Rejection
Ronald Witteles 8
Large-scale testing (Phase 3)Study completedNCT00000935
What this trial is testing

An Evaluation of IV Gamma Globulin As a Method to Improve Kidney Transplant Survival in Patients With End-Stage Renal Disease Who Are Highly Sensitized to Transplant Antigens

Who this might be right for
End-Stage Renal DiseaseKidney Transplantation
National Institute of Allergy and Infectious Diseases (NIAID) 100
Early research (Phase 1)Study completedNCT00143741
What this trial is testing

Use of Atorvastatin (Lipitor) to Decrease Panel Reactive Antibody Titers

Who this might be right for
End-Stage Kidney Disease
University of Chicago 20
Testing effectiveness (Phase 2)Study completedNCT04779957
What this trial is testing

Evaluation of the Safety of Use of Anti-IL6 Receptor Antibodies to Reduce Allo-sensitization Post Allograft Nephrectomy

Who this might be right for
Kidney TransplantationGraft Failure
University Hospital, Toulouse 18
Early research (Phase 1)WithdrawnNCT04088903
What this trial is testing

Study of Daratumumab for Decreasing Circulating Antibodies in Sensitized Patients Awaiting Heart Transplantation

Who this might be right for
AllosensitizationHeart Transplant Failure and Rejection
Ronald Witteles
Not applicableNot Yet RecruitingNCT06802822
What this trial is testing

Prevent Allosensitization in Patients Who Have Failed a First Renal Transplant (PART)

Who this might be right for
Kidney TransplantKidney Transplant FailureImmunosuppresion
University of British Columbia 96